Trial Outcomes & Findings for Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens (NCT NCT04476784)
NCT ID: NCT04476784
Last Updated: 2021-10-26
Results Overview
Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). On Day 30, VA was assessed after 6-8 hours of wear. A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.
COMPLETED
NA
66 participants
Day 1, Day 30 after 6-8 hours of wear, each product
2021-10-26
Participant Flow
Subjects were enrolled at 5 investigative sites located in the United States.
This reporting group includes all subjects/eyes (66/132) exposed to any study lenses evaluated in this study as treated (Safety Analysis Set)
Unit of analysis: eyes
Participant milestones
| Measure |
LID018869, Then Biofinity
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
Biofinity, Then LID018869
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
|---|---|---|
|
First Wear Period (30 Days ± 2 Days)
STARTED
|
31 62
|
35 70
|
|
First Wear Period (30 Days ± 2 Days)
COMPLETED
|
30 60
|
35 70
|
|
First Wear Period (30 Days ± 2 Days)
NOT COMPLETED
|
1 2
|
0 0
|
|
Second Wear Period (30 Days ± 2 Days)
STARTED
|
30 60
|
35 70
|
|
Second Wear Period (30 Days ± 2 Days)
COMPLETED
|
30 60
|
35 70
|
|
Second Wear Period (30 Days ± 2 Days)
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
| Measure |
LID018869, Then Biofinity
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
Biofinity, Then LID018869
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
|---|---|---|
|
First Wear Period (30 Days ± 2 Days)
Withdrawal by Subject
|
1
|
0
|
Baseline Characteristics
Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
Baseline characteristics by cohort
| Measure |
LID018869, Then Biofinity
n=31 Participants
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
Biofinity, Then LID018869
n=35 Participants
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
Total
n=66 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.6 years
STANDARD_DEVIATION 8.0 • n=5 Participants
|
33.7 years
STANDARD_DEVIATION 8.7 • n=7 Participants
|
33.2 years
STANDARD_DEVIATION 8.3 • n=5 Participants
|
|
Sex: Female, Male
Female
|
24 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
52 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
31 Participants
n=5 Participants
|
35 Participants
n=7 Participants
|
66 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
30 Participants
n=5 Participants
|
34 Participants
n=7 Participants
|
64 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
31 participants
n=5 Participants
|
35 participants
n=7 Participants
|
66 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 1, Day 30 after 6-8 hours of wear, each productPopulation: Full Analysis Set: All randomized subjects who are exposed to any study lenses evaluated in this study.
Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). On Day 30, VA was assessed after 6-8 hours of wear. A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.
Outcome measures
| Measure |
LID018869
n=132 eyes
Lehfilcon A contact lenses worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
Biofinity
n=130 eyes
Comfilcon A contact lenses worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
|
|---|---|---|
|
Mean Distance Visual Acuity (logMAR) With Study Lenses
Day 1
|
-0.11 logMAR
Standard Deviation 0.08
|
-0.13 logMAR
Standard Deviation 0.08
|
|
Mean Distance Visual Acuity (logMAR) With Study Lenses
Day 30, after 6-8 hours of wear
|
-0.12 logMAR
Standard Deviation 0.07
|
-0.13 logMAR
Standard Deviation 0.08
|
Adverse Events
Pretreatment
LID018869 - Ocular
LID018869 - Nonocular
Biofinity - Ocular
Biofinity - Nonocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER